Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Assay Drug Dev Technol ; 17(8): 339-351, 2019.
Article in English | MEDLINE | ID: mdl-31846362

ABSTRACT

Repurposing of drugs/natural or synthetic chemicals is a promising approach to identify the new therapeutic indication/use and mode of action. In pharmaceuticals, this process is used to save the time and cost for the drug discovery process with reduced risk of failure. In the present studies, repurposing of a natural molecule: sabinene (major phytochemical in cardamom) was used to characterize the new biological activities using in silico as well as in vitro approaches. In silico similarity searching demonstrated that (+)-3-carene possessed the maximum structural similarity with sabinene. In vitro activities of (+)-3-carene were repurposed for sabinene based on similarity hypothesis (similar structures may have similar biological activities). In vitro studies demonstrated that sabinene is having antimicrobial activity and also showed concentration-dependent antioxidant activity by 2,2-diphenyl-1-picrylhydrazyl scavenging assay. Sabinene treatment protected the yeast cells from hydrogen peroxide-induced cytotoxicity in 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay. Moreover, it was found that sabinene treatment decreased the generation of oxidative stress and also decreased the activities of antioxidant enzymes; glutathione S-transferase, catalase, and lipid peroxidase as compared with untreated yeast cells. Sabinene was also found to have angiostatic and antiangiogenic effects. These results were supported by molecular docking studies against antiangiogenic targets. Therefore, the results of these studies suggested that structurally similar molecules are having the same activity. The phytochemical repurposing using in silico similarity searching as well as in vitro approaches can also be applied for other phytochemicals whose activities are not/less known. Furthermore, this could also be useful in the novel lead/scaffold discovery and target fishing.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bicyclic Monoterpenes/pharmacology , Biological Products/pharmacology , Drug Repositioning , Molecular Docking Simulation , Phytochemicals/pharmacology , Anti-Bacterial Agents/chemistry , Bicyclic Monoterpenes/chemistry , Biological Products/chemistry , Biphenyl Compounds/antagonists & inhibitors , Cell Survival/drug effects , Dose-Response Relationship, Drug , Drug Discovery , Escherichia coli/drug effects , Humans , Molecular Structure , Phytochemicals/chemistry , Picrates/antagonists & inhibitors , Saccharomyces cerevisiae/cytology
2.
J Commun Dis ; 43(1): 17-23, 2011 Mar.
Article in English | MEDLINE | ID: mdl-23785878

ABSTRACT

CONS are the major cause of nosocomial infection in last decade and methicillin resistant CoNS has emerged as a major clinical problem. The present study was to compare different phenotypic methods with genotypic method PCR, for the detection of methicillin resistance in CoNS. 100 CoNS isolates from different samples were studied for the detection of mecA gene. PCR was considered as "gold standard". Oxacillin and cefoxitin antibiotics were used for different phenotypic tests (DD, Agar dilution and MHOX). The sensitivities of oxacillin and cefoxitin disks for all CONS were found to be 92.30% and 88.46% respectively and the specificities were 87.5% and 100% respectively. The sensitivities of the agar dilution test for oxacillin and cefoxitin were 86.53% and 80.76%, respectively, where as the specificities were 79.16% and 85.41%, respectively. The sensitivity of MHOX was observed to be 96.16% and specificity 72.91%. Cefoxitin D.D and oxacillin AD methods could be used as initial test for the determination of methicillin resistance in CoNS isolates. The result of MHOX shows that it could be the best single method for the evaluation of oxacillin resistance mediated by the mecA gene for all CoNS species.


Subject(s)
Anti-Bacterial Agents/pharmacology , Methicillin Resistance , Polymerase Chain Reaction/methods , Staphylococcus/drug effects , Staphylococcus/isolation & purification , Cefoxitin/pharmacology , Disk Diffusion Antimicrobial Tests , Genotype , Humans , Oxacillin/pharmacology , Sensitivity and Specificity , Staphylococcus/genetics
3.
J Burn Care Res ; 31(2): 264-8, 2010.
Article in English | MEDLINE | ID: mdl-20182377

ABSTRACT

The objective of the study is to determine the prevalence of Pseudomonas aeruginosa from burn patients, antibiotic resistance pattern and occurrence of acquired MBL-producing P. aeruginosa among isolates collected from burn patients. In this study, two phenotypic methods were used for the detection of MBL-producing P. aeruginosa: zone enhancement with EDTA-impregnated imipenem and ceftazidime discs, and modified Hodge test. One hundred fifty-four isolates of P. aeruginosa were obtained from July 2007 to July 2008. Infection was increased up to 95% in hospitalized patients for >50 days. Highest infection of 39% was found in patients, who had 41 to 50% of burn area followed by 19% in patients with 31 to 40% of burn area. The most common bacteria isolated were P. aeruginosa (55.0%), followed by Staphylococcus aureus (19.29%) and Klebsiella spp. (11.43%). Sixteen percent isolates of P. aeruginosa were positive for metallo-beta-lactamase production by both methods. Antibiotic resistance pattern of MBL-positive strains showed the highest resistance to ceftazidime (70%) followed by chloramphenicol (68%) and gentamicin (62.5%). Routine detection of MBLs ensuring optimal patient care and careful in vitro testing before antibiotic use may help in the prevention and treatment of burn patients infected with metallo-beta- lactamase-producing P. aeruginosa.


Subject(s)
Anti-Bacterial Agents/pharmacology , Burns/microbiology , Pseudomonas Infections/enzymology , Pseudomonas aeruginosa/enzymology , Adult , Cross Infection/drug therapy , Cross Infection/enzymology , Cross Infection/epidemiology , Cross Infection/microbiology , Drug Resistance, Bacterial , Female , Humans , India/epidemiology , Male , Microbial Sensitivity Tests , Middle Aged , Prevalence , Pseudomonas Infections/drug therapy , Pseudomonas Infections/epidemiology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/isolation & purification
4.
Trop Doct ; 39(2): 109-11, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19299299
5.
J Commun Dis ; 41(2): 93-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-22010496

ABSTRACT

CoNS are the major cause of nosocomial infection in last decade and methicillin resistant CoNS has emerged as a major clinical problem. The present study was to compare different phenotypic methods with genotypic method PCR, for the detection of methicillin resistance in CoNS. 100 CoNS isolates from different samples were studied for the detection of mecA gene. PCR was considered as "gold standard". Oxacillin and cefoxitin antibiotics were used for different phenotypic tests (DD, Agar dilution and MHOX). The sensitivities of oxacillin and cefoxitin disks for all CoNS were found to be 92.30% and 88.46% respectively and the specificities were 87.5% and 100% respectively. The sensitivities of the agar dilution test for oxacillin and cefoxitin were 86.53% and 80.76%, respectively, where as the specificities were 79.16% and 85.41%, respectively. The sensitivity of MHOX was observed to be 96.16% and specificity 72.91%. Cefoxitin D.D and oxacillin AD methods could be used as initial test for the determination of methicillin resistance in CoNS isolates. The result of MHOX shows that it could be the best single method for the evaluation of oxacillin resistance mediated by the mecA gene for all CoNS species.


Subject(s)
Bacterial Typing Techniques/methods , Methicillin Resistance , Staphylococcus/classification , Coagulase/biosynthesis , Cross Infection/microbiology , Genotype , Humans , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/enzymology , Methicillin-Resistant Staphylococcus aureus/genetics , Phenotype , Staphylococcal Infections/microbiology , Staphylococcus/drug effects , Staphylococcus/enzymology , Staphylococcus/genetics
6.
J Assoc Physicians India ; 53: 513-20, 2005 Jun.
Article in English | MEDLINE | ID: mdl-16121805

ABSTRACT

AIM OF THE STUDY: Microalbuminuria is currently the only diagnostic tool available for early diagnosis of diabetic nephropathy. The test is based on immunological detection of small quantities of albumin in the urinary samples of diabetes patients. There are several limitations of the use of microalbuminuria as an index of renal function. It is therefore desirable to identify additional protein markers that would augment prediction of diabetic nephropathy. The aim of this study is to identify urinary protein markers for specific and more accurate prediction of nephropathy in diabetes patients. DESIGN: 100 registered Type II diabetic patients were studied. Abundant proteins of microalbuminuria positive urinary samples of these patients were analyzed by proteomics approaches of 2-Dimentional Gel Electrophoresis (2DGE) and mass spectrometry. RESULTS: 2-DGE analysis of the urine sample revealed four main proteins along with albumin in these samples. These were zinc alpha-2 glycoprotein, alpha-1 acid glycoprotein, alpha-1 microglobulin and IgG as identified by Matrix Assisted Laser Desorption Ionization-Tune of Flight (MALDI-ToF) and by western blot. Twenty control samples and three cases with microalbuminuria negative to positive transition does suggest the early and co-appearance of the markers with albumin. We have also analyzed full length spectrum of these samples by MALDI-ToF. CONCLUSION: Our study shows the presence of additional proteins in urine samples of microalbuminuria positive diabetes patients. These proteins can be used as markers for specific and accurate clinical analysis of Diabetic nephropathy. We propose a mass spectrometry based high throughput diagnostic approach to detect these markers in the urine sample.


Subject(s)
Alpha-Globulins/urine , Carrier Proteins/urine , Diabetic Nephropathies/urine , Glycoproteins/urine , Orosomucoid/urine , Proteinuria/urine , Adipokines , Adult , Alpha-Globulins/genetics , Biomarkers/urine , Carrier Proteins/genetics , Diabetic Nephropathies/diagnosis , Glycoproteins/genetics , Humans , Middle Aged , Orosomucoid/genetics , Proteinuria/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...